Literature DB >> 22549601

Sensitivity of the evaluation of social interaction measures among people with and without neurologic or psychiatric disorders.

Mette Søndergaard1, Anne G Fisher.   

Abstract

OBJECTIVE: To determine whether the Evaluation of Social Interaction (ESI) is sensitive enough to differentiate between people without identified diagnoses and those with neurologic or psychiatric disorders in terms of their observed quality of social interaction.
METHOD: Participants were age 16-69 and were without identified diagnoses (n = 304) or had neurologic (n = 77) or psychiatric (n = 104) disorders. They were evaluated using the ESI.
RESULTS: Nonparametric Kruskal-Wallis tests and post hoc Mann-Whitney U tests revealed that the group without identified diagnoses had significantly better quality of social interaction than did either group with disabilities (Us = 3,172 and 3,189, respectively; p ≤ .001).
CONCLUSION: The ESI is sensitive with regard to detecting differences in quality of social interaction among groups expected to differ, suggesting that it is valid for use when the desired purpose is to identify people with diminished quality of social interaction.
Copyright © 2012 by the American Occupational Therapy Association, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22549601     DOI: 10.5014/ajot.2012.003582

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  3 in total

1.  Experiences of Veterans Transitioning to Postsecondary Education.

Authors:  Brian T Gregg; Dana M Howell; Anne Shordike
Journal:  Am J Occup Ther       Date:  2016 Nov/Dec

Review 2.  Evaluating the Psychometric Quality of Social Skills Measures: A Systematic Review.

Authors:  Reinie Cordier; Renée Speyer; Yu-Wei Chen; Sarah Wilkes-Gillan; Ted Brown; Helen Bourke-Taylor; Kenji Doma; Anthony Leicht
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

Review 3.  Functional assessment in mental health: lessons from occupational therapy.

Authors:  Joan C Rogers; Margo B Holm
Journal:  Dialogues Clin Neurosci       Date:  2016-06       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.